CM
CME
Quarter ended Jun 30, 2024 · FY2024 Q2

CME Group (CME) Revenue — Quarter Ended Jun 30, 2024

Revenue for the reporting quarter increased compared to the prior quarter and rose relative to the same quarter one year earlier. The company reported higher revenue on both sequential and year-over-year bases.

Key takeaway

Quarter ended Jun 30, 2024 · FY2024 Q2

Revenue for the reporting quarter increased compared to the prior quarter and rose relative to the same quarter one year earlier. The company reported higher revenue on both sequential and year-over-year bases.

Financial snapshot

Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.

Quarter revenue

$1.5B

Revenue reported for this quarter.

Quarter-over-quarter

+3.0%

Change from the immediately preceding quarter.

Year-over-year

+12.7%

Change from the comparable year-ago quarter.

Trailing four quarters

$5.8B

Sum of the latest four reported quarters.

Quarterly revenue trend

The latest four reported quarters with year-over-year comparisons.

Period endedRevenueYear-over-year change
Sep 30, 2023$1.3B+9.0%
Dec 31, 2023$1.4B+19.2%
Mar 31, 2024$1.5B+3.2%
Jun 30, 2024$1.5B+12.7%

Revenue performance

Revenue direction was positive, with the reported amount higher than both the immediately preceding quarter and the same quarter of the prior year. The trend data shows revenue has increased in each of the last four quarters.

Quarterly comparison

Compared with the preceding quarter, revenue improved. On a year-over-year basis, revenue also increased versus the same period one year earlier.

What to watch

The filing context notes an increase in net cash from operating activities largely due to an increase in revenues, but does not discuss specific drivers of the revenue change.